Tashman, Joshua W.
Shiwarski, Daniel J.
Feinberg, Adam W.
Funding for this research was provided by:
National Institutes of Health (F30HL154728)
National Institutes of Health (K99HL155777)
U.S. Food and Drug Administration (R01FD006582)
Article History
Received: 11 September 2022
Accepted: 20 December 2022
First Online: 31 December 2022
Competing interests
: A.W.F. has an equity stake in FluidForm Inc., which is a startup company commercializing FRESH 3D printing. FRESH 3D printing is the subject of patent protection including U.S. Patent 10,150,258 and provisional patent No. 63/082621. No other authors have conflicts of interests.